chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA lot # N005605, expiration date 08-APR-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 49 degrees Fahrenheit to for 12 hours. Data logger was involved. There were some previous temperature excursion reported, of 57 degrees Fahrenheit to for 4 hours. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1709USA009147.
Zostavax was administered about 9:00 am. by 9:30 am had developed extremely itchy palms, then feet. 25 mg Diphenylhydramine HCL taken at 9:45 am and another at 11:30 am. Symptoms of itchiness resolved. On 7/22/2014 noted skin around injection site raised and red. Another 25 mg. diphenhydramine HCL take at 8:00 pm.
Pt received DTaP #4 on R th. on 11/5/02. Presented our office on 11/7/02 with redness, swelling, warm to touch on R th started on 11/6/02.
Chest pain, shortness of breath. Took inhaler without effect. Went to ER for trearment
w/in 30min p/vax pt had high loud screech cry that was unconsolable for 3hr;short nap (10 min) & then resumed crying for rest of the evening approx 8-9hr;pt did not nurse until middle of noc;resumed nl behavior p/48hr
Patient reports having numbness and tingling on her lips 6-7 hours after vaccine. Also complains of having numbness in fingertips. Woke up a day later with complaints of HA. All other symptoms subsided
2 days after second dose of Moderna I got random bruises and hives all over my body and a week later it?s still here
Patient received vaccine on 3/20, full body itching started on 3/21, "bumps and itching" on 3/22 and 3/23, presents to clinic on 3/24 with red rash remaining, did not use and medications or request them. States he never had an allergic reaction before.
patient have a migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (patient have a migraine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since 2000 and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE for Thyroid disorder NOS.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced MIGRAINE (patient have a migraine). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Migraine, at a dose of 2 dosage form. At the time of the report, MIGRAINE (patient have a migraine) had resolved. Not Provided          Action taken with vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Reporter's address was updated. Patient's demographics were added. Information about both the doses of Moderna vaccine was updated. Medical history, concomitant medications and treatment medications were added. Outcome of the event was updated from unknown to recovered.
This spontaneous report as received from a nurse practitioner via healthcare worker refers to a multiple unspecified patients of unknown demographics. On an unknown dates the patients received improperly stored VARIVAX (Merck) lot # L019126 with expiration date: 27-MAY-2016; (strength, dose number, dose and route was not reported). Concomitant medication was not reported. No adverse effect was reported. Product quality complaint (PQC) was not involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Tingling on the left side of my face; slight tightness in my throat; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat). At the time of the report, PARAESTHESIA (Tingling on the left side of my face) and THROAT TIGHTNESS (slight tightness in my throat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment information was not provided.
Rash on stomach and back; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had his/her first shingles shot and had a rash on my stomach and back. The patient wanted to know was that serious. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Narrative: 50 yo male was observed to have dizziness during his second  dose of covid19 vaccine on 3/9/2021. Pt also experienced the same symptom  with his dose on 2/16/2021. Symptom resolved within an hour.
Pharmacist accidentally punctured patient's right arm with empty syringe. Patient had mild bleeding from injection needle. Upon discovery of event, pharmacist administered new syringe and needle with Pfizer COVID-19 vaccine into patient's right arm.
Client shared that after the vaccinator gave the vaccine, they squired some out prior to placing it in the sharps bin. Client shared the vaccinator said "sometimes there's some trapped in there"     Completed VAERS report with client. No other treatment provided.
1-2" p/child rec'd vax, she c/o stomach upset, became very pale lethargic though still able to speak, + weakened over all of body. Mom took her to ER at time of arrival, she had returned to her normal self, happy & alert & actively moving.
Six hours after vaccine, extreme muscle aches; splitting, nauseating headache across the forehead.  All symptoms resolved 30-36 hours post vaccine
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 14-Apr-2022 which had got expired on 22-Jan-2022) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 14-Apr-2022 which had got expired on 22-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 14-Apr-2022 which had got expired on 22-Jan-2022) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient received the second booster dose. Patient received the vaccine on 14-Apr-2022 which had got expired on 22-Jan-2022. Concomitant drugs were not reported. Treatment details were not given.
Mild headache; BP 148/75 (pulse 83); final BP 146/61 (pulse 71).
Left deltoid of arm with induration, redness, and warmth. No neurological problems.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Information on patient's pertinent medical history, drug reactions/allergies and concomitant medications were not provided. On an unknown date the patient was inadvertently vaccinated with the third dose of GARDASIL dose 3 (route, strength, dosage, indication, lot number and expiration date were unreported). The reporting pharmacist had limited information. No adverse event was reported. No product quality complaints were reported. No additional information available. Additional information has been requested.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with a dose of improperly stored ZOSTAVAX 19400 PFU (lot # M019646, expiration date 18-JUL-2017, dose and route not reported). There were multiple temperature excursions, and the highest temperature was reported as 26 degree Fahrenheit. Data logger was not involved. Additional information has been requested.
Starting the day after the injection she began experiencing fever up to 103 degrees F, chills and body aches.
She called and stated that again she had body aches, headache. But this time her left arm
5 month old male given KINRIX. Phone calls and message made to parents and emergency contact with no response, to inquire about adverse events.
Mom noticed redness on left leg 11-10, redness was larger and leg swollen on 11-11. She noticed water filled blisters in center of redness on 11-12. Redness measures 10 cm x 10 cm, hot to touch. Rx'd SEPTRA susp. 7 mL.
for 5 weeks she has had parethesia right leg, paroxysmal tachycardis/svt Narrative:
Provided Trumemba (Meningococcal B) to a 11 year-9 month old instead of Menongiococcal Conjugate.
DIARRHEA, COUGH , PNEUMONIA STARTING 4/27/2021
fever up to 102 x 2 days; body aches; headache. Currently has headache and brain fog.
Small red circle with rash. Advised cold compress and Infant Tylenol if needed. DTAP was given SQ in arm.
Adverse effect of other vaccines and biological substances, initial encounter on 2021-01-11.
Exacerbation of exema on hands Hives on both inner forearms ,back and chest
Diarrhea around 6:30pm and 7:45 and 8 Low grade headache and tiredness early evening
Burning sensation and hurt at injection site; This case was reported by a nurse via call center representative and described the occurrence of injection site burning in a patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   On an unknown date, the patient received the 1st dose of Fluarix Quadrivalent 2019-2020 season. On an unknown date, less than a year after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced injection site burning. On an unknown date, the outcome of the injection site burning was unknown.   It was unknown if the reporter considered the injection site burning to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The reporter reported that more than one patient experienced burning sensation and hurt at injection site, after receiving 1st dose of Fluarix Quadrivalent. No other information was reported. The reporter consented to follow up.
Headache, Myalgia, CoughWheeze, NauseaVomiting, Syncope, tested negative with rapid per covid Narrative:
it was rpt the same day of vax pt devel a fever 105f, abd pain & heart murmur. MD assumed murmur assoc w/fever. pt treated w/tylenol & sent home
5 days after my injection, I noticed a raised, bumpy area on my L upper arm.  At this time, I did not equate this with my injection since it was 5 days later.  But on day 6 in the AM, the area on my L deltoid was visible and red in the mirror.  It took my husband and I a few minutes to put together that this was the site of my injection.  Throughout the day, the area was raised, red, and itchy- but not intolerable and I did not take any medication.  I did put some hydrocortizone ointment on the area this PM (still day 6 post-injection).
The injection site started to swell aprox. 2 hours after injection.  The next day the patient reported a fever of 102 degrees and nausea. Patient received treatment by physician for the nausea.
This spontaneous report as received from a nurse refers to a patient of unknown gender. The patient was vaccinated with dose 1 of M-M-R II (reported lot number 1769AA; expiry date 10-NOV-2013) on 01-OCT-2012. Dose and route of administration were not reported. The vaccine had been improperly stored (not further specified). No adverse event was reported. The nurse reported 5 patients who received incorrectly stored ROTATEQ oral (case IDs 1210USA002302, 1210USA006259, 1210USA006260, 1210USA006261, and 1210USA006262), all on the same day. Additional information has been requested.
no adverse effect reported; received one dose of improperly stored ROTATEQ; This spontaneous report was received from an office manager refers to a patient of unknown age and gender. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 05-AUG-2019, the patient was vaccinated with one dose of improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (lot # R025713, expiry date 20-JUN-2020, dose, strength, route, vaccination site unspecified) for prophylaxis (product storage error). The vaccine was stored at a temperature of 33.9 degree fahrenheit for time frame of 20 minutes. It was further mentioned as the most recent temperature in which Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) included total time and lowest temperature below 36 degree fahrenheit (33.9 degree fahrenheit) and updated the timeframe to 40 minutes, instead of the previously reported 20 minutes.  The vaccine's previous temperature excursion included previous excursions reported as total time and lowest temperature below 36 degree fahrenheit (30.3 degree fahrenheit) for 90 hours and 7 minutes, Total time and lowest temperature below 36 degree fahrenheit (30.5 degree fahrenheit) for 1 hour 45 minutes and total time and lowest temperature below 36 degree fahrenheit (35.2 degree fahrenheit) for 2 hours 5 minutes (30.3 degree fahrenheit for 93 hours and 50 minutes). Digital data logger was involved. No adverse effects were reported.
Right now she is experiencing a fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Right now she is experiencing a fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ETANERCEPT (ENBREL), METHOTREXATE, SERTRALINE, ARIPIPRAZOLE (ABILIFY), ALPRAZOLAM (XANAX), HYDROMORPHONE, FENTANYL, PREDNISONE and OXYBUTYNIN for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PYREXIA (Right now she is experiencing a fever). At the time of the report, PYREXIA (Right now she is experiencing a fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No corrective treatment was provided.
pt recv vax & devel an inj site rxn characterized by swelling & a knot;pt recovered p/2 to 3 wk;
Assigned to work at nursing location. I reported for duty on 12/23/2020 @ 1310  and was offered the vaccine. No reaction at that time. Several hrs into my shift I became ill. Nausea, vomiting, trouble breathing, tongue was feeling funny, dizzy, stomach pain, extreme fatigue and lightheaded.  I immediately reported to the charge nurse on the floor then shortly called my registry informing them of the current events. Registry offered to call 911 and I declined. Registry gave permission to end of shift and go home.. However when I notifed the charge nurse on the floor she stated I can't leave because she was leaving for the day. She called supervisor.  I spoke to him and explained the situation and he informed me another person whom was a MD also was experiencing the same symtpoms. He instructed me to stay in the room I was at and they will send orange juice it should make me feel better. I waited and waited. I called the sup back and informed him my symptoms are getting worse and need to go. At this time I had developed a severe headache. I was not able to continue with extremely HEAVY workload caring 29 COVID patients in my condition and sup allowed me to go home. He said he would talk to the floor nurse because he had already arranged for 2 nurses to come in 7 pm which was shortly.  Once home, my husband said I had a blank stare and dazed. Several hrs later I developed a fever, cough and severe body pain.  I remained in bed for several days and most symptoms resolved. However on the 4th day went out and within a few started to become short of breath and heaviness on my chest and attempted the following day going outside and the same thing. I continue to have intermittent stomach pains and coughing.
Cold sweat within 5-10 minutes of both injections.  Severe migraines, exhaustion, and technicolor dreaming after both shots.  After the second shot I had a fever of 101-102F, extreme body aches (24 hrs),  extreme migraines for 48 hours or more,  projectile vomiting for 4 hours followed by extreme gastric upset and diarrhea, poor focus, exhaustion lasted for at least one week.
ABDOMINAL PAIN STARTED SLOWLY AND GRADUALLY, BECAME MORE INTENSE OVERNIGHT; ACHY AREA IN THE TUMMY; ACUTE APPENDICITIS; This spontaneous report received from a patient concerned a 52 year old,  female. The patient's weight was 144 pounds, and height was 62 inches. The patient's concurrent conditions included hypertension - symptomatic, alcoholic, non smoker, and appendectomy, and other pre-existing medical conditions included the patient had no known allergies. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, and expiry: unknown) dose was not reported, once total, administered on 10-APR-2021 at right arm for prophylactic vaccination. Concomitant medications included losartan for hypertension-symptomatic.  On an unspecified date in APR-2021, the patient experienced acute appendicitis and achy area in the tummy. Performed a computed tomography and an abdominal ultrasound, were performed and acute appendicitis was diagnosed. Recovery had been gone well; some achy area in the tummy. On 22-APR-2021 patient started to experience abdominal pain - started whole abdomen then started localizing to the right of the abdomen. Pain started slowly and gradually, became more intense overnight, went to work the next day, needed to leave work early and went to the emergency room, admitted her directly into the hospital. It was unknown that when the patient was discharged. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from abdominal pain started slowly and gradually, became more intense overnight, and the outcome of acute appendicitis and achy area in the tummy was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: 20210451696-COVID-19 VACCINE AD26.COV2.S-Acute appendicitis, abdominal pain started slowly and gradually, became more intense overnight. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Pt complaint she doesn't feel well, doesn't want to do anything. Headache, chills (cold feet), runny nose, increase heart rate. Fainting spell. She only went to ER on 10/27/17 due to intense headache. She was sent home to take TYLENOL EXT STR. She also had F/U with primary care and again on Feb 1 2018 due to increase heart rate and headache. Dr called 911 sent to ER. Sent home with med to prevent stroke.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 18-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) dose, route and anatomical location were not provided. There was no concomitant medication provided. On an unknown date, the PNEUMOVAX had a temperature excursion for 1800 hours, the highest recorded temperature was 59.9 F (15.5 Celsius). The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
stomach viruses; strep throat; Initial information received on 07-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer through social media.  This case involves patient (unknown demographics) who experienced stomach viruses and strep throat, while he/she received vaccine INFLUENZA VACCINE.  The patient's past vaccination(s) included INFLUENZA VACCINE and experienced sick (patient worked with toddlers-adorable little germ factories that like to sneeze directly into your eyeballs after they lick the window and eat a cheerio they found on the playgeound. hadn't missed work in over 4 years).  Medical history, medical treatment, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious stomach viruses four times and strep throat two times, (unknown latency) following the administration of INFLUENZA VACCINE. It was reported that patient missed 15 days of work in that time.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of events was reported as unknown (not reported).  There will be no information available on the batch number for this case.
Approximately 5 minutes after vaccination, patient complained of feeling light-headed. His face appeared pale and he attempted to walk a couple of steps to get on the exam table and began to faint. He was caught by myself and his mother and guided to the floor without injury. The initial episode was very brief (seconds) and the patient was conscious and speaking by the time he was completely supine on the floor. He was provided a cool compress to the forehead for approximately 3 minutes until he felt able to stand to get to the table. Once flat on the table with legs raised, he was provided apple juice until he was able to sit and eventually stand and then walk to the car without light-headedness (approximately 20 minutes).